These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19909083)

  • 1. Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses.
    Liu Y; McNevin J; Rolland M; Zhao H; Deng W; Maenza J; Stevens CE; Collier AC; McElrath MJ; Mullins JI
    J Infect Dis; 2009 Dec; 200(12):1825-33. PubMed ID: 19909083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.
    Keane NM; Roberts SG; Almeida CA; Krishnan T; Chopra A; Demaine E; Laird R; Tschochner M; Carlson JM; Mallal S; Heckerman D; James I; John M
    Immunol Cell Biol; 2012 Feb; 90(2):224-34. PubMed ID: 21577229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.
    Novitsky V; Cao H; Rybak N; Gilbert P; McLane MF; Gaolekwe S; Peter T; Thior I; Ndung'u T; Marlink R; Lee TH; Essex M
    J Virol; 2002 Oct; 76(20):10155-68. PubMed ID: 12239290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa.
    Dorrell L; Dong T; Ogg GS; Lister S; McAdam S; Rostron T; Conlon C; McMichael AJ; Rowland-Jones SL
    J Virol; 1999 Feb; 73(2):1708-14. PubMed ID: 9882385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection.
    Fryer HR; Scherer A; Oxenius A; Phillips R; McLean AR
    Proc Biol Sci; 2009 Dec; 276(1677):4389-97. PubMed ID: 19776069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells.
    Streeck H; Jolin JS; Qi Y; Yassine-Diab B; Johnson RC; Kwon DS; Addo MM; Brumme C; Routy JP; Little S; Jessen HK; Kelleher AD; Hecht FM; Sekaly RP; Rosenberg ES; Walker BD; Carrington M; Altfeld M
    J Virol; 2009 Aug; 83(15):7641-8. PubMed ID: 19458000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes.
    Schaubert KL; Price DA; Salkowitz JR; Sewell AK; Sidney J; Asher TE; Blondelle SE; Adams S; Marincola FM; Joseph A; Sette A; Douek DC; Ayyavoo V; Storkus W; Leung MY; Ng HL; Yang OO; Goldstein H; Wilson DB; Kan-Mitchell J
    Eur J Immunol; 2010 Jul; 40(7):1950-62. PubMed ID: 20432235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women.
    Musey L; Hu Y; Eckert L; Christensen M; Karchmer T; McElrath MJ
    J Exp Med; 1997 Jan; 185(2):293-303. PubMed ID: 9016878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid characterization of HIV clade C-specific cytotoxic T lymphocyte responses in infected African children and adults.
    Goulder PJ
    Ann N Y Acad Sci; 2000 Nov; 918():330-45. PubMed ID: 11131720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-synonymous Substitutions in HIV-1 GAG Are Frequent in Epitopes Outside the Functionally Conserved Regions and Associated With Subtype Differences.
    Olusola BA; Olaleye DO; Odaibo GN
    Front Microbiol; 2020; 11():615721. PubMed ID: 33505382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topological perspective on HIV escape.
    McMichael AJ; Carrington M
    Science; 2019 May; 364(6439):438-439. PubMed ID: 31048479
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the HIV-1 Polymerase Gene Sequence Diversity for Prediction of Recent HIV-1 Infections Using Shannon Entropy Analysis.
    Nkone P; Loubser S; Quinn TC; Redd AD; Laeyendecker O; Tiemessen CT; Mayaphi SH
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep sequencing of the HIV-1 polymerase gene for characterisation of cytotoxic T-lymphocyte epitopes during early and chronic disease stages.
    Nkone P; Loubser S; Quinn TC; Redd AD; Ismail A; Tiemessen CT; Mayaphi SH
    Virol J; 2022 Mar; 19(1):56. PubMed ID: 35346259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines.
    Wee EG; Moyo N; Hannoun Z; Giorgi EE; Korber B; Hanke T
    Mol Ther Methods Clin Dev; 2021 Jun; 21():741-753. PubMed ID: 34169114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute-Phase CD4
    Sutton MS; Ellis-Connell A; Moriarty RV; Balgeman AJ; Gellerup D; Barry G; Weiler AM; Friedrich TC; O'Connor SL
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection.
    Munson P; Liu Y; Bratt D; Fuller JT; Hu X; Pavlakis GN; Felber BK; Mullins JI; Fuller DH
    Hum Vaccin Immunother; 2018 Jul; 14(7):1820-1831. PubMed ID: 29648490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 prophylactic vaccines: state of the art.
    Lelièvre JD; Lévy Y
    J Virus Erad; 2016 Jan; 2(1):5-11. PubMed ID: 27482428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New prospects for a preventive HIV-1 vaccine.
    Brown J; Excler JL; Kim JH
    J Virus Erad; 2015 Apr; 1(2):78-88. PubMed ID: 26523292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV DNA Vaccine: Stepwise Improvements Make a Difference.
    Felber BK; Valentin A; Rosati M; Bergamaschi C; Pavlakis GN
    Vaccines (Basel); 2014 May; 2(2):354-79. PubMed ID: 26344623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types.
    Migueles SA; Mendoza D; Zimmerman MG; Martins KM; Toulmin SA; Kelly EP; Peterson BA; Johnson SA; Galson E; Poropatich KO; Patamawenu A; Imamichi H; Ober A; Rehm CA; Jones S; Hallahan CW; Follmann DA; Connors M
    EBioMedicine; 2015 Jan; 2(1):46-58. PubMed ID: 26137533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.